Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase

被引：54

作者：

Metzgeroth, G. ^{[1
]}

Schwaab, J. ^{[1
]}

Gosenca, D. ^{[1
]}

Fabarius, A. ^{[1
]}

Haferlach, C. ^{[2
]}

Hochhaus, A. ^{[3
]}

Cross, N. C. P. ^{[4
,5
]}

Hofmann, W-K ^{[1
]}

Reiter, A. ^{[1
]}

机构：

[1] Univ Med Mannheim, Med Klin 3, Mannheim, Germany

[2] Munchner Leukamie Lab, Munich, Germany

[3] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany

[4] Wessex Reg Genet Lab, Salisbury, Wilts, England

[5] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England

来源：

LEUKEMIA | 2013年 / 27卷 / 11期

关键词：

GROWTH-FACTOR RECEPTOR; MYELOPROLIFERATIVE DISORDERS; HYPEREOSINOPHILIC SYNDROME; FUSION GENE; FIP1L1-PDGFRA; ABNORMALITIES; LEUKEMIA; EFFICACY; MESYLATE;

D O I：

10.1038/leu.2013.129

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2254 / 2256

页数：4

共 12 条

[1] Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta [J].

Apperley, JF ;

Gardembas, M ;

Melo, JV ;

Russell-Jones, R ;

Bain, BJ ;

Baxter, J ;

Chase, A ;

Chessells, JM ;

Colombat, M ;

Dearden, CE ;

Dimitrijevic, S ;

Mahon, FX ;

Marin, D ;

Nikolova, Z ;

Olavarria, E ;

Silberman, S ;

Schultheis, B ;

Cross, NCP ;

Goldman, JM .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :481-487

[2] The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study [J].

Baccarani, Michele ;

Cilloni, Daniela ;

Rondoni, Michela ;

Ottaviani, Emanuela ;

Messa, Francesca ;

Merante, Serena ;

Tiribelli, Mario ;

Buccisano, Francesco ;

Testoni, Nicoletta ;

Gottardi, Enrico ;

de Vivo, Antonio ;

Giugliano, Emilia ;

Iacobucci, Ilaria ;

Paolini, Stefania ;

Soverini, Simona ;

Rosti, Gianantonio ;

Rancati, Francesca ;

Astolfi, Cinzia ;

Pane, Fabrizio ;

Saglio, Giuseppe ;

Martinelli, Giovanni .

HAEMATOLOGICA, 2007, 92 (09) :1173-1179

[3] Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 [J].

Bain, Barbara J. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05) :696-698

[4] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].

Cools, J ;

DeAngelo, DJ ;

Gotlib, J ;

Stover, EH ;

Legare, RD ;

Cortes, J ;

Kutok, J ;

Clark, J ;

Galinsky, I ;

Griffin, JD ;

Cross, NCP ;

Tefferi, A ;

Malone, J ;

Alam, R ;

Schrier, SL ;

Schmid, J ;

Rose, M ;

Vandenberghe, P ;

Verhoef, G ;

Boogaerts, M ;

Wlodarska, I ;

Kantarjian, H ;

Marynen, P ;

Coutre, SE ;

Stone, R ;

Gilliland, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) :1201-1214

[5] Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders [J].

Cross, Nicholas C. P. ;

Reiter, Andreas .

ACTA HAEMATOLOGICA, 2008, 119 (04) :199-206

[6] Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders [J].

David, Marianna ;

Cross, Nicholas C. P. ;

Burgstaller, Sonja ;

Chase, Andrew ;

Curtis, Claire ;

Dang, Raymond ;

Gardembas, Martine ;

Goldman, John M. ;

Grand, Francis ;

Hughes, George ;

Huguet, Francoise ;

Lavender, Louise ;

McArthur, Grant A. ;

Mahon, Francois X. ;

Massimini, Giorgio ;

Melo, Junia ;

Rousselot, Philippe ;

Russell-Jones, Robin J. ;

Seymour, John F. ;

Smith, Graeme ;

Stark, Alastair ;

Waghorn, Katherine ;

Nikolova, Zariana ;

Apperley, Jane F. .

BLOOD, 2007, 109 (01) :61-64

[7] Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis [J].

Erben, Philipp ;

Gosenca, Darko ;

Mueller, Martin C. ;

Reinhard, Jelena ;

Score, Joannah ;

del Valle, Francesco ;

Walz, Christoph ;

Mix, Juergen ;

Metzgeroth, Georgia ;

Ernst, Thomas ;

Haferlach, Claudia ;

Cross, Nicholas C. P. ;

Hochhaus, Andreas ;

Reiter, Andreas .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05) :738-744

[8] Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias [J].

Gotlib, J. ;

Cools, J. .

LEUKEMIA, 2008, 22 (11) :1999-2010

[9] Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia [J].

Helbig, Grzegorz ;

Moskwa, Andrzej ;

Hus, Marek ;

Piszcz, Jaroslaw ;

Swiderska, Alina ;

Urbanowicz, Alina ;

Calbecka, Malgorzata ;

Seferynska, Ilona ;

Razny, Malgorzata ;

Rodzaj, Marek ;

Zuk, Ewa ;

Kyrcz-Krzemien, Slawomira .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) :967-969

[10] Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma [J].

Metzgeroth, G. ;

Walz, C. ;

Score, J. ;

Siebert, R. ;

Schnittger, S. ;

Haferlach, C. ;

Popp, H. ;

Haferlach, T. ;

Erben, P. ;

Mix, J. ;

Mueller, M. C. ;

Beneke, H. ;

Mueller, L. ;

Del Valle, F. ;

Aulitzky, W. E. ;

Wittkowsky, G. ;

Schmitz, N. ;

Schulte, C. ;

Mueller-Hermelink, K. ;

Hodges, E. ;

Whittaker, S. J. ;

Diecker, F. ;

Doehner, H. ;

Schuld, P. ;

Hehlmann, R. ;

Hochhaus, A. ;

Cross, N. C. P. ;

Reiter, A. .

LEUKEMIA, 2007, 21 (06) :1183-1188

← 1 2 →